Description du projet
Renforcer la capacité de recherche translationnelle au Portugal
L’Institut de médecine moléculaire (IMM) de Lisbonne, au Portugal, est un institut de recherche biomédicale qui promeut la recherche fondamentale, clinique et translationnelle dans le domaine des sciences de la vie. Le projet EXCELLtoINNOV, financé par l’UE, vise à renforcer l’excellence de l’IMM en matière de recherche sur l’immunité et l’infection par le recrutement d’une chaire EER. Cela permettra de créer un pôle de recherche à Lisbonne et de positionner l’IMM à l’avant-garde dans ce domaine. La stratégie consiste à perfectionner le personnel et améliorer les infrastructures de recherche, à développer le potentiel de recherche de l’IMM, à soutenir la formation de pôles d’innovation avec le secteur privé et à améliorer sa visibilité internationale. Ces efforts renforceront la compétitivité de l’IMM en termes de financement de la recherche et permettront de nouer de nouvelles collaborations à l’échelle mondiale.
Objectif
EXCELLtoINNOV will provide IMM with the needed means to achieve excellence on a sustainable basis through the recruitment of an ERA Chair in translational biomedical research in immunity and infection. This goal will be strategically achieved by placing IMM in the forefront of Research, Development and Innovation (R&D+I) in immunity and infection, through the establishment of a translational biomedical research hub anchored in Lisbon that will: i. leverage the national potential beyond borders; ii. act as the interface of Europe with America and Africa; iii. and effectively contribute to overcome the health and demographic change societal challenges by potentiating major scientific advancements in this research area through worldwide collaborative efforts. The successful implementation of this strategy will be possible through specific activities, including: 1) the development of a new research field at IMM by the ERA Chair holder, pre-clinical molecular and imaging studies, that will transversally benefit and impact all research areas at IMM; 2) the implementation of structural changes at IMM to successfully support and comply with ERA priorities; 3) the expansion of overseas collaborations in international collaborative R&D+I projects; and 4) an improved integration of IMM in the regional, national and international business community. Through the completion of these activities we will achieve an improved capability to compete successfully for internationally competitive research funding, including but not limited to Horizon 2020, IMI2 and EDCTP2 as well as effectively contribute to the objectives of regional smart specialisation strategies through increased international attractiveness, competitiveness and innovation potential of IMM, Lisbon and Portugal.
Champ scientifique
Mots‑clés
Programme(s)
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Thème(s)
Régime de financement
CSA - Coordination and support actionCoordinateur
1649 028 Lisboa
Portugal